📰 Dave Fredrickson News
Page 7 - Dave Fredrickson News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dave Fredrickson. Real-time updates on events, politics, business and more.
June 1, 2023
LYNPARZA combination showed a clinically meaningful reduction in risk of disease progression or death in these patients in the Phase 3 PROpel trial First approval of a PARP inhibitor in combination... | June 1, 2023
June 1, 2023
Miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
June 1, 2023
AstraZeneca PLC on Thursday hailed another approval for cancer drug Lynparza, while it ceased its development programme for Crohns disease-focused brazikumab. The Cambridge-based pharmaceutical... | June 1, 2023
June 1, 2023
LYNPARZA combination reduced the risk of disease progression or death by 76% vs. abiraterone alone First PARP inhibitor approved in combination with a novel hormonal agent underscores clinically... | June 1, 2023
June 1, 2023
Olaparib plus abiraterone and prednisone or prednisolone already is approved in the European Union and several other countries.
June 1, 2023
Investigators previously reported a statistically significant improvement in radiographic progression-free survival in the full intention-to-treat population of adults with deleterious or suspected deleterious BRCA-mutated metastatic castration-resistant prostate cancer.
March 23, 2023
Acalabrutinib has received conditional approval from the National Medical Products Administration in China for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy.
March 3, 2023
Rose Joy Crutchfield Sundberg peacefully returned to her Creator on Feb. 25, 2023, at the age of 90. She was surrounded by family that loves...
February 22, 2023
The tablet formulation for AZ's BTK inhibitor has gained EU approval for co-administration with gastric acid-reducing agents in leukaemia.
February 9, 2023
Investegate announcements from AstraZeneca PLC, Final Results